rivaroxaban taro 10 mg
taro pharmaceutical industries ltd - rivaroxaban - film coated tablets - rivaroxaban 10 mg - rivaroxaban - * prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.* prevention of recurrent deep vein thrombosis (dvt) and pulmonary embolism (pe), in adults (following completion of at least 6 months therapy for dvt or pe).
rivaroxaban taro 15 mg
taro pharmaceutical industries ltd - rivaroxaban - film coated tablets - rivaroxaban 15 mg - rivaroxaban - paediatric populationtreatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment.
rivaroxaban taro 20 mg
taro pharmaceutical industries ltd - rivaroxaban - film coated tablets - rivaroxaban 20 mg - rivaroxaban - * prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age≥75 years, diabetes mellitus, prior stroke or transient ischaemic attack.* treatment of deep vein thrombosis (dvt), and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults.paediatric populationtreatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing 50 kg after at least 5 days of initial parenteral anticoagulation treatment.
coumadin 1 mg
taro pharmaceutical industries ltd - warfarin sodium - tablets - warfarin sodium 1 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.
coumadin 2 mg
taro pharmaceutical industries ltd - warfarin sodium - tablets - warfarin sodium 2 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonar embolism. coumadin is indicated for the prophylaxis and/or treatment of the tromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.
coumadin 2.5 mg
taro pharmaceutical industries ltd - warfarin sodium - tablets - warfarin sodium 2.5 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.
coumadin 5 mg
taro pharmaceutical industries ltd - warfarin sodium - tablets - warfarin sodium 5 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonar embolis. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.
etopan 400
taro pharmaceutical industries ltd - etodolac - tablets - etodolac 400 mg - etodolac - etodolac - for the management of signs and symptoms of osteoarthritis and rheumatoid arthritis. for the management of pain.
etopan 200
taro pharmaceutical industries ltd - etodolac - capsules - etodolac 200 mg - etodolac - etodolac - for the management of signs and symptoms of osteoarthritis and rheumatoid arthritis. for the management of pain.
etopan 300
taro pharmaceutical industries ltd - etodolac - capsules - etodolac 300 mg - etodolac - etodolac - for the management of signs and symptoms of osteoarthritis and rheumatoid arthritis. for the management of pain.